Ribavirin aerosol approved for severe cases of RSV in infants and young children.
D000336:Aerosols; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D009153:Mutagens; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000188:drug therapy*; D012254:Ribavirin / Q000008:administration & dosage* / Q000009:adverse effects; D012263:Ribonucleosides / Q000008:administration & dosage*; D013723:Teratogens; D014481:United States; D014486:United States Food and Drug Administration
D000336:Aerosols; D009153:Mutagens; D012263:Ribonucleosides; D013723:Teratogens; D012254:Ribavirin